NEWSROOM 新闻室

Updates from GenTide 睿联生物 动态

Company milestones, scientific publications, awards, and media coverage. 公司里程碑、科研成果、获奖动态与媒体报道。

Latest News 最新动态

What we've been building 我们近期的进展

🚀
Company 公司动态
2026

GenTide Biotech Established 睿联生物科技正式成立

GenTide founded with a mission to reshape drug discovery using AI large models and structural biology. Offices established in Shanghai, with global reach to Singapore and San Jose. 睿联生物科技正式成立,以 AI 生物大模型与结构生物学重构药物发现范式。总部设于上海,业务延伸至新加坡与圣何塞。

💊 Coming Soon 即将发布
Pipeline 研发管线
2026

Nav1.8 Pain Program Advances as Primary License-Out Candidate Nav1.8 疼痛项目确立为首要对外授权候选管线

Stay tuned for updates on GenTide's Nav1.8 selective inhibitor program targeting the non-opioid pain market. 敬请期待睿联 Nav1.8 选择性抑制剂项目的最新进展公告。

📰 Coming Soon 即将发布
News 动态
2026

More Updates Coming 更多动态即将发布

Stay tuned for upcoming announcements on partnerships, pipeline milestones, and company news. 敬请期待关于合作、管线进展与公司动态的最新公告。

Stay in Touch 保持联系

Get notified when we have news 第一时间获取我们的最新动态

For media enquiries, press kits, or to be notified of future announcements, contact our communications team. 如需媒体询问、新闻素材包或希望第一时间获得最新公告,请联系我们的传播团队。

Contact Us 联系我们